Ranking · Trials

Trial termination share

Share of interventional studies first posted since 2010 that ended TERMINATED or WITHDRAWN among those that reached a terminal status (COMPLETED, TERMINATED, WITHDRAWN). Registrant-reported statuses; reasons are shown as posted and never inferred. Requires ≥ 30 terminal studies.

Computedci-trial-termination-v1unit: ratiohigher = worseAll metrics

Rank	Δ	Cancer	Trial termination share (ratio)	Percentile	Confidence	Sources	Why #n?
1	=	Malignant Hypopharyngeal Neoplasm	0.41	100	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 70 completed 41 studyType INTERVENTIONAL withdrawn 9 terminated 20 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569664
2	=	Malignant Kidney Neoplasm	0.38	97	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 627 completed 387 studyType INTERVENTIONAL withdrawn 54 terminated 186 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569665
3	=	Malignant Mesothelioma	0.37	93.9	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 179 completed 112 studyType INTERVENTIONAL withdrawn 15 terminated 52 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569666
4	=	Cutaneous Melanoma	0.36	90.9	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 108 completed 69 studyType INTERVENTIONAL withdrawn 4 terminated 35 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569667
5	=	Leukemia	0.36	87.9	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 2544 completed 1639 studyType INTERVENTIONAL withdrawn 230 terminated 675 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569668
6	=	Non-Hodgkin Lymphoma	0.35	84.8	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 2730 completed 1761 studyType INTERVENTIONAL withdrawn 256 terminated 713 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569669
7	=	Skin Carcinoma	0.35	81.8	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 133 completed 86 studyType INTERVENTIONAL withdrawn 21 terminated 26 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569670
8	=	Malignant Testicular Neoplasm	0.35	78.8	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 51 completed 33 studyType INTERVENTIONAL withdrawn 6 terminated 12 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569671
9	=	Malignant Central Nervous System Neoplasm	0.35	75.8	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 974 completed 634 studyType INTERVENTIONAL withdrawn 92 terminated 248 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569672
10	=	Malignant Lung Neoplasm	0.35	72.7	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 3116 completed 2031 studyType INTERVENTIONAL withdrawn 267 terminated 818 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569673
11	=	Malignant Pancreatic Neoplasm	0.34	69.7	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 1154 completed 756 studyType INTERVENTIONAL withdrawn 121 terminated 277 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569674
12	=	Malignant Oropharyngeal Neoplasm	0.34	66.7	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 160 completed 105 studyType INTERVENTIONAL withdrawn 22 terminated 33 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569675
13	=	Malignant Laryngeal Neoplasm	0.34	63.6	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 88 completed 58 studyType INTERVENTIONAL withdrawn 9 terminated 21 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569676
14	=	Multiple Myeloma	0.34	60.6	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 1196 completed 789 studyType INTERVENTIONAL withdrawn 113 terminated 294 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569677
15	=	Malignant Ovarian Neoplasm	0.33	57.6	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 941 completed 632 studyType INTERVENTIONAL withdrawn 71 terminated 238 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569678
16	=	Malignant Liver Neoplasm	0.32	54.5	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 1096 completed 740 studyType INTERVENTIONAL withdrawn 129 terminated 227 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569679
17	=	Malignant Bladder Neoplasm	0.31	51.5	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 467 completed 321 studyType INTERVENTIONAL withdrawn 45 terminated 101 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569680
18	=	Malignant Vaginal Neoplasm	0.29	48.5	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 41 completed 29 studyType INTERVENTIONAL withdrawn 4 terminated 8 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569681
19	=	Malignant Esophageal Neoplasm	0.29	45.5	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 445 completed 318 studyType INTERVENTIONAL withdrawn 37 terminated 90 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569682
20	=	Malignant Rectal Neoplasm	0.28	42.4	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 396 completed 285 studyType INTERVENTIONAL withdrawn 31 terminated 80 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569683
21	=	Hodgkin Lymphoma	0.28	39.4	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 350 completed 253 studyType INTERVENTIONAL withdrawn 21 terminated 76 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569684
22	=	Malignant Uterine Corpus Neoplasm	0.28	36.4	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 478 completed 346 studyType INTERVENTIONAL withdrawn 34 terminated 98 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569685
23	=	Malignant Anal Neoplasm	0.27	33.3	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 70 completed 51 studyType INTERVENTIONAL withdrawn 4 terminated 15 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569686
24	=	Malignant Gallbladder Neoplasm	0.27	30.3	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 48 completed 35 studyType INTERVENTIONAL withdrawn 4 terminated 9 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569687
25	=	Malignant Prostate Neoplasm	0.27	27.3	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 1907 completed 1391 studyType INTERVENTIONAL withdrawn 158 terminated 358 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569688
26	=	Malignant Colon Neoplasm	0.27	24.2	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 402 completed 294 studyType INTERVENTIONAL withdrawn 36 terminated 72 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569689
27	=	Malignant Lip and Oral Cavity Neoplasm	0.26	21.2	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 175 completed 129 studyType INTERVENTIONAL withdrawn 15 terminated 31 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569690
28	=	Malignant Gastric Neoplasm	0.26	18.2	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 692 completed 511 studyType INTERVENTIONAL withdrawn 41 terminated 140 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569691
29	=	Malignant Thyroid Gland Neoplasm	0.26	15.2	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 193 completed 143 studyType INTERVENTIONAL withdrawn 15 terminated 35 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569692
30	=	Malignant Breast Neoplasm	0.26	12.1	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 3846 completed 2860 studyType INTERVENTIONAL withdrawn 308 terminated 678 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569693
31	=	Malignant Nasopharyngeal Neoplasm	0.24	9.1	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 141 completed 107 studyType INTERVENTIONAL withdrawn 4 terminated 30 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569694
32	=	Malignant Cervical Neoplasm	0.23	6.1	High confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 568 completed 439 studyType INTERVENTIONAL withdrawn 39 terminated 90 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569695
33	=	Malignant Salivary Gland Neoplasm	0.21	3	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 84 completed 66 studyType INTERVENTIONAL withdrawn 4 terminated 14 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569696
34	=	Malignant Vulvar Neoplasm	0.21	0	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 since 2010-01-01 terminal 47 completed 37 studyType INTERVENTIONAL withdrawn 3 terminated 7 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minTerminalTrials 30 ranking row 2569697

Data updated 17 hours agoSource updated unknown34 eligible entities · inputs hash f9abfb651589cac1f9e339e2